-
Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
Monday, April 29, 2024 - 4:42pm | 1014"Over 131 million people in the United States, that’s over 66% of the population, are currently prescribed to a prescription medication," said Courtney Barnes, a partner at a New York-based cannabis and psychedelics law firm Feldman Legal Advisors. "Of those prescription medications available...
-
20 Most Influential Women In The Cannabis Industry And The Secret To Meet Them In Person In 2024
Friday, March 8, 2024 - 5:24pm | 3330To celebrate International Women’s Day, it’s essential to shine a light on the women making strides in the Cannabis industry, a field historically dominated by men. These remarkable women are set to share their experiences and wisdom at the upcoming Benzinga Cannabis Capital...
-
EXCLUSIVE: In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
Friday, April 14, 2023 - 10:51am | 873Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental health conditions and how clinical data is crucial to pulling institutional...
-
G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma
Monday, January 24, 2022 - 12:21pm | 341Greenridez 2.0 Acquisitions Corp. confirmed Friday that it has completed its acquisition of psychedelic research company Lophos Pharma, which is primarily concentrated on new therapeutic treatments derived from Peyote (Lophophora williamsii). The Toronto-based company confirmed that it...